Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer

Weill Cornell Medical College, New York

Stony Brook University Medical Center, Stony Brook

Urologic Consultants of Southeastern PA, LLP, Bala-Cynwyd

Fox Chase Cancer Center, Rockledge

Thomas Jefferson University, Philadelphia

Montgomery General Hospital, Olney

Johns Hopkins University, Baltimore

Duke University Medical Center, Durham

Northeast Urology Research, Concord

Medical University of South Carolina, Charleston

University of Georgia / Regents Medical Center, Augusta

Florida Urology Partners - Tampa Bay, Clearwater

Morton Plant Hospital, Clearwater

Cleveland Clinic, Cleveland

University of Michigan, Ann Arbor

University of Wisconsin, Madison

University of Minnesota, Minneapolis

Mayo Clinic, Rochester

University of Chicago, Chicago

Washington University, St Louis

Louisiana State University Health Science Center, Shreveport

University of Oklahoma Peggy and Charles Stephenson Cancer Center, Oklahoma City

University of Colorado Cancer Center, Aurora

VA Greater Los Angeles Healthcare, Los Angeles

University of California, Los Angeles, Los Angeles

City of Hope Cancer Center, Duarte

University of California San Francisco, San Francisco

Virginia Mason Medical Center, Seattle

University of Washington School of Medicine, Seattle

Yale Cancer Center, New Haven

Lahey Clinic, Burlington

Cooper Health System, Camden

University of Pennsylvania, Philadelphia

Prostate Cancer Centre, Calgary, AB

Lions Gate Hospital, North Vancouver

Cancer Care Manitoba, Winnipeg

Cancer Care Nova Scotia, Halifax

Ottawa Hospital Research Institute, University of Ottawa, Ottawa

Sunnybrook Health Sciences Centre, Toronto

Princess Margaret Cancer Centre, Toronto

Hôtel-Dieu de Québec, Québec

Centre hospitalier de l'Université de Montréal (CHUM), Montreal

Jewish General Hospital, Montreal

MUHC, Montreal

Centre d'imagerie moléculaire de Sherbrooke, Sherbrooke